Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Gene therapy for cystic fibrosis shows encouraging results

Boehringer Ingelheim, IP Group, the UK Cystic Fibrosis Gene Therapy Consortium and Oxford Biomedica, have announced that Boehringer Ingelheim has exercised its options on intellectual property and know-how from the partners to progress and further accelerate the development of a potential, new treatment option for patients with cystic fibrosis.

Professors Deborah Gill and Stephen Hyde are founding members of the UK CF Gene Therapy Consortium in 2001, a consortium of scientists and clinicians that continues to work toward making gene therapy a reality for patients with cystic fibrosis.

Professor Gill said "We have been working closely with Boehringer Ingelheim and Oxford Biomedica since 2018 and this acceleration of our gene therapy programme for patients with cystic fibrosis is very exciting for our research team.”   

Professor Hyde added "The collaborative nature of this project, including the long-running UK Cystic Fibrosis Gene Therapy Consortium that brought together researchers from three UK Universities, has been an important driver of our progress. We hope to continue to build on this."

Find out more about the research done by the Gill and Hyde Gene Medicine Research group

Read the full announcement

 

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

New Studentship honours Enzo Cerundolo

A new Studentship has been announced in memory of the late MRC HIU Director and MRC WIMM Group Leader.

Doug Higgs awarded the 2023 Genetics Society Medal

The award recognises Professor Higgs' major contribution to our understanding of how mammalian genes are switched on and off, and using haematopoiesis as a model to understand how genes function.

2022 RDM Graduate Prize Winners

This year's winners are Edward Jenkins, Antje Rottner, and Akshay Shah.

KJ Patel appointed new Chief Scientist of CRUK

Alongside his new role at Cancer Research UK, Prof. Patel will continue as the Director of both the MRC Weatherall Institute for Molecular Medicine (MRC WIMM) and the MRC Molecular Haematology Unit (MRC MHU).

Anjali Kusumbe receives the RMS Life Sciences Medal

The Royal Microscopical Society awards celebrate the best in microscopy, recognising those making a special contribution to microscopy, cytometry and imaging.